New York, June 7 (BNA): Pfizer Inc said it will spend $120 million to expand manufacturing of its COVID-19 antiviral treatment at its Michigan plant, as demand increases.
Reuters reported that the use of the birth control pill, Baxlovid, which is authorized to treat newly infected and at-risk patients to prevent severe disease, has recently risen as infections have risen.
Biden administration officials have pushed for greater use of Baxlovid, which the government distributes free of charge.
MI